Literature DB >> 11943826

Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression.

Yukihiko Shirayama1, Andrew C-H Chen, Shin Nakagawa, David S Russell, Ronald S Duman.   

Abstract

Previous studies demonstrated that antidepressant treatment increases the expression of brain-derived neurotrophic factor (BDNF) in rat hippocampus. The present study was conducted to test the hypothesis that BDNF in the hippocampus produces an antidepressant effect in behavioral models of depression, the learned helplessness (LH) and forced swim test (FST) paradigms. A single bilateral infusion of BDNF into the dentate gyrus of hippocampus produced an antidepressant effect in both the LH and FST that was comparable in magnitude with repeated systemic administration of a chemical antidepressant. These effects were observed as early as 3 d after a single infusion of BDNF and lasted for at least 10 d. Similar effects were observed with neurotrophin-3 (NT-3) but not nerve growth factor. Infusions of BDNF and NT-3 did not influence locomotor activity or passive avoidance. The results provide further support for the hypothesis that BDNF contributes to the therapeutic action of antidepressant treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943826      PMCID: PMC6757539          DOI: 20026292

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  41 in total

1.  Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain.

Authors:  T Ueyama; Y Kawai; K Nemoto; M Sekimoto; S Toné; E Senba
Journal:  Neurosci Res       Date:  1997-06       Impact factor: 3.304

2.  BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain.

Authors:  L A Mamounas; C A Altar; M E Blue; D R Kaplan; L Tessarollo; W E Lyons
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

Review 3.  The forced swimming test as a model for core and component behavioral effects of antidepressant drugs.

Authors:  I Lucki
Journal:  Behav Pharmacol       Date:  1997-11       Impact factor: 2.293

4.  Hippocampal volume reduction in major depression.

Authors:  J D Bremner; M Narayan; E R Anderson; L H Staib; H L Miller; D S Charney
Journal:  Am J Psychiatry       Date:  2000-01       Impact factor: 18.112

5.  Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression.

Authors:  Y I Sheline; M Sanghavi; M A Mintun; M H Gado
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

6.  Neurotrophin-evoked rapid excitation through TrkB receptors.

Authors:  K W Kafitz; C R Rose; H Thoenen; A Konnerth
Journal:  Nature       Date:  1999-10-28       Impact factor: 49.962

7.  Effects of adverse experiences for brain structure and function.

Authors:  B S McEwen
Journal:  Biol Psychiatry       Date:  2000-10-15       Impact factor: 13.382

8.  Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression.

Authors:  A Russo-Neustadt; R C Beard; C W Cotman
Journal:  Neuropsychopharmacology       Date:  1999-11       Impact factor: 7.853

9.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

Authors:  M A Smith; S Makino; R Kvetnansky; R M Post
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

10.  Brain-derived neurotrophic factor causes cAMP response element-binding protein phosphorylation in absence of calcium increases in slices and cultured neurons from rat visual cortex.

Authors:  T Pizzorusso; G M Ratto; E Putignano; L Maffei
Journal:  J Neurosci       Date:  2000-04-15       Impact factor: 6.167

View more
  461 in total

Review 1.  Depression, antidepressants, and neurogenesis: a critical reappraisal.

Authors:  Nicola D Hanson; Michael J Owens; Charles B Nemeroff
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

2.  Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles.

Authors:  Babak Baseri; James J Choi; Thomas Deffieux; Gesthimani Samiotaki; Yao-Sheng Tung; Oluyemi Olumolade; Scott A Small; Barclay Morrison; Elisa E Konofagou
Journal:  Phys Med Biol       Date:  2012-03-09       Impact factor: 3.609

Review 3.  Brain-derived neurotrophic factor and neuropsychiatric disorders.

Authors:  Anita E Autry; Lisa M Monteggia
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

4.  Effects of antidepressant drug imipramine on gene expression in rat prefrontal cortex.

Authors:  Juha E A Knuuttila; Petri Törönen; Eero Castrén
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

Review 5.  Increased expression of the anti-apoptotic protein Bcl-xL in the brain is associated with resilience to stress-induced depression-like behavior.

Authors:  Nikolay N Dygalo; Tatyana S Kalinina; Veta V Bulygina; Galina T Shishkina
Journal:  Cell Mol Neurobiol       Date:  2012-01-26       Impact factor: 5.046

Review 6.  Structural and synaptic plasticity in stress-related disorders.

Authors:  Daniel J Christoffel; Sam A Golden; Scott J Russo
Journal:  Rev Neurosci       Date:  2011       Impact factor: 4.353

Review 7.  Linking molecules to mood: new insight into the biology of depression.

Authors:  Vaishnav Krishnan; Eric J Nestler
Journal:  Am J Psychiatry       Date:  2010-09-15       Impact factor: 18.112

8.  Hippocampal PPARα is a novel therapeutic target for depression and mediates the antidepressant actions of fluoxetine in mice.

Authors:  Lu Song; Hao Wang; Ying-Jie Wang; Jin-Liang Wang; Qing Zhu; Feng Wu; Wei Zhang; Bo Jiang
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

9.  Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response.

Authors:  Eric J Peters; Susan L Slager; Greg D Jenkins; Megan S Reinalda; Holly A Garriock; Stanley I Shyn; Jeffrey B Kraft; Patrick J McGrath; Steven P Hamilton
Journal:  Pharmacogenet Genomics       Date:  2009-01       Impact factor: 2.089

10.  Fluoxetine exposure during adolescence alters responses to aversive stimuli in adulthood.

Authors:  Sergio D Iñiguez; Lyonna F Alcantara; Brandon L Warren; Lace M Riggs; Eric M Parise; Vincent Vialou; Katherine N Wright; Genesis Dayrit; Steven J Nieto; Matthew B Wilkinson; Mary K Lobo; Rachael L Neve; Eric J Nestler; Carlos A Bolaños-Guzmán
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.